Amynas

Foundation date

23/12/2019

Sector

#Medical Technology

Subsector

Amynas’ lead candidate product is a bio-envelope made of electrospun nanofibers designed to promote healthy tissue growth around the implant (anti-inflammatory and anti-scarring) and reduce the infection rate, resulting in fewer re-admission rates for post-surgical complications.

Upcoming events

Latest news

  • Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China

    1 day ago

  • Celyad announces management change

    Friday December 1st 2023

  • Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States

    Thursday November 30th 2023